AI Provides Faster Diagnosis for Debilitating Blistering Disease
Scientists have trained an artificial intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita.
Category: Allergy & Autoimmune
Allergy & Autoimmune
Latest
Allergy & Autoimmune
Latest
BARDA Awards Contract for Rapid Coronavirus In-Home Self-Test
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Allergy & Autoimmune
Latest
Owlstone Medical Provides Breath Biopsy Analysis to Study of Immune-Mediated Diseases
The company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Assay Supports Drug Development for Autoimmune Disease
The disease stratification assay is designed to support pharmaceutical and biotechnology companies with their drug development efforts for systemic sclerosis.
Read More
United Rheumatology Adds Multibiomarker Blood Test to Clinical Guidelines
The guidelines are designed to assist healthcare professionals in the diagnosis, treatment, and monitoring of patients with rheumatoid arthritis.
Read More
Environmental Trigger Test Evaluates Latent Pathogens
The test assesses the immune load from 29 bacterial, fungal, parasitic, stealth, and viral organism antigens that may be latent in the body.
Read More
Tests Facilitate Autoimmune Thyroid Disease Management
The tests quantitatively measure a patient’s autoantibodies to thyroglobulin or thyroid peroxidase, providing information that can help clinicians in the diagnosis of autoimmune thyroid disease.
Read More
Protagen Joins Global Consortium Examining Rheumatoid Arthritis
The RA-MAP consortium aims to identify clinical, molecular and cellular biomarkers of prognosis and therapeutic response in patients with early RA.
Read More
FDA Clears Nut Allergen Component Tests
The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.
Read More
Allergies and Autoimmune Diseases
The incidence of allergies and autoimmune diseases has been increasing over the past several decades, with both diseases rising to become a major women’s issue.
Read More
Rheumatoid Arthritis Blood Test Gains Expanded Use Indications
In addition to assisting with early diagnosis, the test’s expanded indications support treat-to-target objectives by allowing close monitoring of 14-3-3η levels along the clinical management path to detect how active the joint damage processes are.
Read More
Autoimmune Platform Holds 800 Tubes
Thermo Fisher Scientific’s Phadia 2500EE, a dedicated autoimmune platform that streamlines operational efficiency, will be featured at AACC booth 3564.
Read More
IES Diagnostics Identifies Body’s Immune Signature for Lupus
IES is launching a crowdfunding campaign to develop the first clinical diagnostic test for systemic lupus erythematosus, based on the unique interferon signature of the disease.
Read More
Immunovent’s Test Aims to Uncover Allergies That Current Allergy Tests Cannot
For Immunovent’s innovative approach to allergy diagnosis, MABA names the company the “best of the best” in its year-end first pitch life science competition.
Read MoreEuropean Deals Widen Availability of Blood Thinner Allergy Assay
Akers Biosciences has entered into multiyear distribution agreements with Cryopep SARL and DiaLine AG for its PIFA Heparin and PF4 rapid assay products, which determine whether a patient being treated with the blood thinner heparin may be developing a drug allergy.
Read More
FDA Authorizes First Commercially Available Screening Test for Severe Combined Immunodeficiency
The Victor EnLite and EnLite Neonatal TREC kit from PerkinElmer is the first commercially available screening test in the United States and Canada for severe combined immunodeficiency, known as “Bubble Boy” disease. Affecting an estimated 1 in 58,000 newborns each year, SCID is an inherited genetic condition that makes it extremely difficult to fight off infections.
Read More
The Food-Sensitization Dilemma
Clinicians and their patients face a dilemma: Patient histories are often unclear, and sensitization alone does not necessarily predict risk for severe systemic reactions.
Read More
Expanded Access to Thermo’s Peanut Allergy Tests through Collaboration with Quest Diagnostics
Quest is the first national company to broadly offer the first and only FDA-cleared component tests able to detect IgE sensitization to five peanut proteins, some of which can cause severe patient reactions.
Read More